ArticleInflammatory intestinal diseases

A Retrospective Comparison of Postoperative Tumor Necrosis Factor-α Inhibitor Continuation versus Ustekinumab Switch in Crohn's Disease: Reset or Switch?

Shuhei Hosomi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.